Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia
Phase 2
Active, not recruiting
- Conditions
- Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
- Interventions
- First Posted Date
- 2015-12-14
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 81
- Registration Number
- NCT02629809
- Locations
- πΊπΈ
M D Anderson Cancer Center, Houston, Texas, United States
Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney Cancer
Early Phase 1
Completed
- Conditions
- Metastatic Renal Cell CancerClear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v7
- Interventions
- Other: Laboratory Biomarker AnalysisProcedure: CryosurgeryProcedure: Therapeutic Conventional SurgeryBiological: Tremelimumab
- First Posted Date
- 2015-12-10
- Last Posted Date
- 2022-07-07
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 29
- Registration Number
- NCT02626130
- Locations
- πΊπΈ
M D Anderson Cancer Center, Houston, Texas, United States
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function
Phase 1
Active, not recruiting
- Conditions
- CirrhosisHepatocellular CarcinomaMetastatic Malignant Neoplasm in the LiverCholangiocarcinoma
- Interventions
- Other: Laboratory Biomarker AnalysisProcedure: Magnetic Resonance ImagingRadiation: Radiation TherapyOther: Survey Administration
- First Posted Date
- 2015-12-10
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 36
- Registration Number
- NCT02626312
- Locations
- πΊπΈ
M D Anderson Cancer Center, Houston, Texas, United States
Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis
Phase 4
Terminated
- Conditions
- Malignant Pleural EffusionsAdvanced Cancers
- Interventions
- Behavioral: QuestionnairesOther: SalineBehavioral: Phone Calls
- First Posted Date
- 2015-12-08
- Last Posted Date
- 2019-08-07
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 3
- Registration Number
- NCT02623959
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation Therapy
Not Applicable
Active, not recruiting
- Conditions
- Head and Neck Carcinoma
- Interventions
- Procedure: Bioelectric Impedance AnalysisProcedure: Computed TomographyProcedure: Positron Emission TomographyOther: Quality-of-Life AssessmentOther: Questionnaire AdministrationRadiation: Radiation Therapy
- First Posted Date
- 2015-11-26
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT02615275
- Locations
- πΊπΈ
M D Anderson Cancer Center, Houston, Texas, United States
Accelerated Enhanced RECOVERy Following Minimally Invasive Colorectal Cancer Surgery (RecoverMI)
Not Applicable
Completed
- Conditions
- Colorectal Cancer
- Interventions
- Behavioral: Standard Enhanced CareBehavioral: Accelerated Recovery PlanBehavioral: Early DischargeOther: Telemedicine
- First Posted Date
- 2015-11-24
- Last Posted Date
- 2022-03-15
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 32
- Registration Number
- NCT02613728
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Safety Evaluation of Intra-Operative MRI-Based Guidance for Laser Ablation of Epidural Metastasis
Not Applicable
Completed
- Conditions
- Spinal Tumor
- Interventions
- Procedure: Magnetic Resonance Imaging (MRI)Behavioral: Questionnaires
- First Posted Date
- 2015-11-24
- Last Posted Date
- 2019-01-10
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 11
- Registration Number
- NCT02613390
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Houston Independent School District (HISD) Yoga Evaluation
Not Applicable
Terminated
- Conditions
- Health and Wellness
- Interventions
- Procedure: ElectroencephalographBehavioral: Cognitive TestsOther: Hair Sample
- First Posted Date
- 2015-11-17
- Last Posted Date
- 2018-10-31
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 5
- Registration Number
- NCT02606591
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma
Early Phase 1
Active, not recruiting
- Conditions
- Smoldering Plasma Cell Myeloma
- Interventions
- Other: Laboratory Biomarker Analysis
- First Posted Date
- 2015-11-13
- Last Posted Date
- 2025-01-23
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT02603887
- Locations
- πΊπΈ
M D Anderson Cancer Center, Houston, Texas, United States
Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer
Phase 1
Recruiting
- Conditions
- Stage IV Pancreatic Cancer AJCC v6 and v7Stage IVB Colorectal Cancer AJCC v7Metastatic Colorectal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage IVA Colorectal Cancer AJCC v7Stage IV Colorectal Cancer AJCC v7
- Interventions
- Biological: Synthetic Tumor-Associated Peptide Vaccine TherapyProcedure: Computed TomographyProcedure: Magnetic Resonance Imaging
- First Posted Date
- 2015-11-09
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 150
- Registration Number
- NCT02600949
- Locations
- πΊπΈ
M D Anderson Cancer Center, Houston, Texas, United States
Β© Copyright 2025. All Rights Reserved by MedPath